Evaluate the Efficacy and Safety of the Prophylactic Use of PEG-rhG-CSF in Children With Hematological Malignancies

NCT04497701 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

139

Enrollment

INDUSTRY

Sponsor class

Conditions

Lymphoma
Leukemia

Interventions

DRUG: PEG-rhG-CSF group
DRUG: rhG-CSF group

Sponsor

CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.

Collaborators

[object Object]